HB3409

View on ILGA

COSMETIC PRODUCTS ACT

What this bill does

Creates the Chemicals in Cosmetic Products Act. Prohibits the manufacture, sale, delivery, holding, or offering for sale of a cosmetic product that contains specific intentionally added chemical ingredients. Exempts cosmetic products that were manufactured with an intent to comply with the Act and contain a technically unavoidable trace quantity of a prohibited chemical ingredient due to certain reasons. Defines terms.

Sponsor: Sonya M. Harper Chamber: House Introduced: 2025-02-07
Stuck
P(Advance)
41.3%
Chance it ever reaches a milestone (committee, floor, etc.). Not “next step.”
P(Law)
29.8%
Chance it becomes law given where it is now (stage, momentum).
Forecast
26.6%
Low P(law) at intro — sponsor & topic only; no progress or delay.
Confidence: 59%

Calculating prediction drivers...

Pipeline Progress

Current stage: Crossed Chambers · Last action 344 days ago

How does a bill become law in Illinois?
  1. Introduction of Bill

    A member of the Senate or the House introduces a bill, which is assigned a unique identifying number (e.g., "H.B. ___" for House bills and "S.B. ___" for Senate bills). If not enacted, it must be reintroduced in the next General Assembly with a new number.

  2. Committee Work — Hearings

    The bill goes to the appropriate committee, which holds hearings to gather expert opinions and determine the need for the legislation.

  3. Committee Work — Markup, Amendments, Report

    The committee may make amendments to the bill. If approved, a committee report endorsing the bill is issued.

  4. Floor Debate

    The bill is debated and can be further amended. The debate transcripts are accessible online for public viewing.

  5. Passage and Consideration in Second Chamber

    If the bill passes in the first chamber, it moves to the second chamber for a similar review process. If both chambers approve, it goes to the governor.

  6. Gubernatorial Action

    The governor can sign the bill into law, veto it, or take no action (resulting in an automatic law after 60 days). The type of veto can be total or amendatory. Once signed, the bill becomes a Public Act and is assigned a Public Act number.

Sponsor Context

Public Engagement

18 witness slips filed 17 proponents / 0 opponents 7 organizations

Witness slips

18 slips filed. Proponent / opponent / no position as filed with the committee.

Name Organization Representing Position Hearing committee Hearing date
Anne McDermott self self Proponent Public Health 2025-03-20
Carrie Felix self self Proponent Public Health 2025-03-20
Cheryl Jones Das Self Self Proponent Public Health 2025-03-20
David Bythewood Constituent Self Proponent Public Health 2025-03-20
Deborah Fenner Self Self Proponent Public Health 2025-03-20
Diane Ostrowski None Self Proponent Public Health 2025-03-20
Karen Goldman Self Self Proponent Public Health 2025-03-20
Kathryn Luedke She Votes IL Proponent Public Health 2025-03-20
Lindsay Morrison self self Proponent Public Health 2025-03-20
Madeline Miley Self Self Proponent Public Health 2025-03-20
Maureen Keane She Votes Illinois She Votes Illinois Proponent Public Health 2025-03-20
Maureen Vana Self Self Proponent Public Health 2025-03-20
Paula Clark Self Self Proponent Public Health 2025-03-20
Rachel Becknell Constituent Self Proponent Public Health 2025-03-20
Shawn Michael self self Proponent Public Health 2025-03-20
Stephanie Holt none self Proponent Public Health 2025-03-20
Susan Jaffee Knit Nirvana llc Business owner Proponent Public Health 2025-03-20
Dan Lewis Illinois Department of Financial and Professional Regulation Illinois Department of Financial and Professional Regulation No Position On Merits Public Health 2025-03-20

Roll-call votes

Total votes and outcome per event. Deciding vote = margin of 1; those voters on the winning side could have changed the outcome by flipping.

Date Chamber Type Description Yea Nay Present NV Outcome Margin Deciding voters
H Committee Public Health 6 3 0 0 Passed 3
H Floor Third Reading 69 38 0 11 Passed 31

Action History

24 actions recorded. Last action: 2025-04-30 — Added as Alternate Chief Co-SponsorSen. Cristina Castro. Each action's meaning and outcome signal are classified automatically.

2025-02-07 Introduction & Filing
Filed with the Clerk byRep. Sonya M. Harper House Rule 6(b)
Bill officially submitted to the House Clerk during the session.
2025-02-18 Introduction & Filing
First Reading Senate Rule 5-1(d)/5-2; House Rule 37(d)/38
Formal introduction — title read into the official record. Required procedural step; bill now exists in the system.
2025-02-18 Committee Assignment
Referred toRules Committee Senate Rule 3-8(a); House Rule 18(a)
Sent to a committee (usually Rules in the House, Assignments in the Senate). The gatekeeping step — Rules/Assignments decides which substantive committee hears the bill.
2025-03-11 Committee Assignment
Assigned toPublic Health Committee Senate Rule 3-8(a); House Rule 18(b)
Sent to a substantive committee (e.g., Transportation, Revenue). This is where the bill gets a real hearing and evaluation.
2025-03-19 Co-Sponsorship Mild +
Added Co-SponsorRep. Lisa Davis Senate Rule 5-1(a); House Rule 37(a)
A legislator adds their name as co-sponsor, signaling public support for the bill.
2025-03-19 Co-Sponsorship Mild +
Added Co-SponsorRep. Kimberly Du Buclet Senate Rule 5-1(a); House Rule 37(a)
A legislator adds their name as co-sponsor, signaling public support for the bill.
2025-03-19 Co-Sponsorship Mild +
Added Chief Co-SponsorRep. La Shawn K. Ford Senate Rule 5-1(a); House Rule 37(a)
Chief co-sponsor added.
2025-03-19 Co-Sponsorship Mild +
Added Chief Co-SponsorRep. Debbie Meyers-Martin Senate Rule 5-1(a); House Rule 37(a)
Chief co-sponsor added.
2025-03-19 Co-Sponsorship Mild +
Added Chief Co-SponsorRep. Yolonda Morris Senate Rule 5-1(a); House Rule 37(a)
Chief co-sponsor added.
2025-03-19 Co-Sponsorship Mild +
Added Chief Co-SponsorRep. Lilian Jiménez Senate Rule 5-1(a); House Rule 37(a)
Chief co-sponsor added.
2025-03-19 Co-Sponsorship Mild +
Added Co-SponsorRep. Kevin John Olickal Senate Rule 5-1(a); House Rule 37(a)
A legislator adds their name as co-sponsor, signaling public support for the bill.
2025-03-20 Committee Action Positive
Do Pass / Short DebatePublic Health Committee; 006-003-000 Senate Rule 3-11(a)(1); House Rule 22(a)(1), 52(b)
Committee recommends passage and places it on the Short Debate calendar (limited floor discussion time). Strong positive signal — committee believes bill has broad support.
2025-03-20 Floor Process Positive
Placed on Calendar 2nd Reading - Short Debate Senate Rule 4-4(7-8)/5-2; House Rule 31(8-9)/38/52
Bill placed on the Second Reading calendar. Positive — bill is queued for floor action.
2025-03-26 Floor Process Positive
Second Reading - Short Debate Senate Rule 3-12(a)/5-4(a); House Rule 24(a)/40(b)/52(a)(1)
Bill reaches the floor amendment stage on Short Debate calendar. Major milestone — bill has passed committee and is on the floor.
2025-03-26 Floor Process
Held on Calendar Order of Second Reading - Short Debate Senate Rule 4-4(7-8)/5-2; House Rule 31(8-9)/38/52
Bill was ready for Second Reading but was paused/held by the sponsor. Usually indicates the sponsor is still negotiating amendments or gathering votes. NOT a negative signal — the sponsor controls the pace.
2025-04-08 Floor Process Positive
Placed on Calendar Order of 3rd Reading - Short Debate Rule 4-4(8)
Bill placed on the Third Reading calendar — queued for final vote.
2025-04-08 Floor Vote Positive
Third Reading - Short Debate - Passed069-038-000 Senate Rule 5-1(f)/7-1/7-2; House Rule 37(f)/49/50
Bill PASSED on Short Debate Third Reading. Bill cleared the chamber.
2025-04-09 Cross-Chamber Positive
Arrive in Senate Senate Rule 5-1(d)/4-4(9-11); House Rule 37(d)/31(10-12)
House bill arrives in the Senate after passing the House.
2025-04-09 Procedural
Placed on Calendar Order of First Reading April 10, 2025 Senate Rule 4-4/7-4; House Rule 31/54
Bill queued for First Reading in the second chamber.
2025-04-23 Cross-Chamber Positive
Chief Senate SponsorSen. Cristina Castro Senate Rule 5-1(d)/4-4(9-11); House Rule 37(d)/31(10-12)
Senate sponsor assigned for a House bill.
2025-04-23 Introduction & Filing
First Reading Senate Rule 5-1(d)/5-2; House Rule 37(d)/38
Formal introduction — title read into the official record. Required procedural step; bill now exists in the system.
2025-04-23 Committee Assignment
Referred toAssignments Senate Rule 3-8(a); House Rule 18(a)
Sent to a committee (usually Rules in the House, Assignments in the Senate). The gatekeeping step — Rules/Assignments decides which substantive committee hears the bill.
2025-04-30 Cross-Chamber
Alternate Chief Sponsor Changed toSen. Mattie Hunter Senate Rule 5-1(d)/4-4(9-11); House Rule 37(d)/31(10-12)
Alternate chief sponsor designated.
2025-04-30 Co-Sponsorship Mild +
Added as Alternate Chief Co-SponsorSen. Cristina Castro Senate Rule 5-1(a); House Rule 37(a)
Alternate chief co-sponsor added.

All actions (table)

Date Chamber Action Category Signal
2025-02-07 House Filed with the Clerk byRep. Sonya M. Harper House Rule 6(b) Introduction & Filing
2025-02-18 House First Reading Senate Rule 5-1(d)/5-2; House Rule 37(d)/38 Introduction & Filing
2025-02-18 House Referred toRules Committee Senate Rule 3-8(a); House Rule 18(a) Committee Assignment
2025-03-11 House Assigned toPublic Health Committee Senate Rule 3-8(a); House Rule 18(b) Committee Assignment
2025-03-19 House Added Co-SponsorRep. Lisa Davis Senate Rule 5-1(a); House Rule 37(a) Co-Sponsorship Mild +
2025-03-19 House Added Co-SponsorRep. Kimberly Du Buclet Senate Rule 5-1(a); House Rule 37(a) Co-Sponsorship Mild +
2025-03-19 House Added Chief Co-SponsorRep. La Shawn K. Ford Senate Rule 5-1(a); House Rule 37(a) Co-Sponsorship Mild +
2025-03-19 House Added Chief Co-SponsorRep. Debbie Meyers-Martin Senate Rule 5-1(a); House Rule 37(a) Co-Sponsorship Mild +
2025-03-19 House Added Chief Co-SponsorRep. Yolonda Morris Senate Rule 5-1(a); House Rule 37(a) Co-Sponsorship Mild +
2025-03-19 House Added Chief Co-SponsorRep. Lilian Jiménez Senate Rule 5-1(a); House Rule 37(a) Co-Sponsorship Mild +
2025-03-19 House Added Co-SponsorRep. Kevin John Olickal Senate Rule 5-1(a); House Rule 37(a) Co-Sponsorship Mild +
2025-03-20 House Do Pass / Short DebatePublic Health Committee; 006-003-000 Senate Rule 3-11(a)(1); House Rule 22(a)(1), 52(b) Committee Action Positive
2025-03-20 House Placed on Calendar 2nd Reading - Short Debate Senate Rule 4-4(7-8)/5-2; House Rule 31(8-9)/38/52 Floor Process Positive
2025-03-26 House Second Reading - Short Debate Senate Rule 3-12(a)/5-4(a); House Rule 24(a)/40(b)/52(a)(1) Floor Process Positive
2025-03-26 House Held on Calendar Order of Second Reading - Short Debate Senate Rule 4-4(7-8)/5-2; House Rule 31(8-9)/38/52 Floor Process
2025-04-08 House Placed on Calendar Order of 3rd Reading - Short Debate Rule 4-4(8) Floor Process Positive
2025-04-08 House Third Reading - Short Debate - Passed069-038-000 Senate Rule 5-1(f)/7-1/7-2; House Rule 37(f)/49/50 Floor Vote Positive
2025-04-09 Senate Arrive in Senate Senate Rule 5-1(d)/4-4(9-11); House Rule 37(d)/31(10-12) Cross-Chamber Positive
2025-04-09 Senate Placed on Calendar Order of First Reading April 10, 2025 Senate Rule 4-4/7-4; House Rule 31/54 Procedural
2025-04-23 Senate Chief Senate SponsorSen. Cristina Castro Senate Rule 5-1(d)/4-4(9-11); House Rule 37(d)/31(10-12) Cross-Chamber Positive
2025-04-23 Senate First Reading Senate Rule 5-1(d)/5-2; House Rule 37(d)/38 Introduction & Filing
2025-04-23 Senate Referred toAssignments Senate Rule 3-8(a); House Rule 18(a) Committee Assignment
2025-04-30 Senate Alternate Chief Sponsor Changed toSen. Mattie Hunter Senate Rule 5-1(d)/4-4(9-11); House Rule 37(d)/31(10-12) Cross-Chamber
2025-04-30 Senate Added as Alternate Chief Co-SponsorSen. Cristina Castro Senate Rule 5-1(a); House Rule 37(a) Co-Sponsorship Mild +